PGI28 UTILIZATION AND COST OF PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN THE MANAGEMENT OF CHRONIC HEPATITIS C VIRUS IN EUROPE

Autor:	C Naujoks, Debanjali Mitra, Bela Bapat, Keith L. Davis, C Leteneux
Rok vydání:	2010
Předmět:	chemistry.chemical_compound Combination therapy Chronic hepatitis chemistry business.industry Health Policy Ribavirin Public Health Environmental and Occupational Health Medicine business Virology Virus
Zdroj:	Value in Health. 13:A73-A74
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)72346-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6732e6fbe2c5a5f8427e6b92f14dcb76 https://doi.org/10.1016/s1098-3015(10)72346-9 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text